Notch inhibition as a promising new approach to cancer therapy.
暂无分享,去创建一个
[1] Y. Taniguchi,et al. Presenilin-dependent “γ-Secretase” Processing of Deleted in Colorectal Cancer (DCC)* , 2003, Journal of Biological Chemistry.
[2] B. Osborne,et al. Notch-1 Regulates NF-κB Activity in Hemopoietic Progenitor Cells1 , 2001, The Journal of Immunology.
[3] Johan Skog,et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.
[4] H. Stein,et al. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. , 2002, Blood.
[5] N. Patel,et al. Inhibition of angiogenesis and tumor growth by and ?-secretase inhibitors , 2005 .
[6] D. Ma,et al. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. , 2009, Leukemia research.
[7] Raymond E. Moellering,et al. Direct inhibition of the NOTCH transcription factor complex , 2009, Nature.
[8] J. Rich,et al. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Gord Fishell,et al. Radial Glial Identity Is Promoted by Notch1 Signaling in the Murine Forebrain , 2000, Neuron.
[10] J. Aster,et al. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. , 2009, Blood.
[11] Hans Clevers,et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.
[12] G. Fishell,et al. Fibroblast Growth Factor Receptor Signaling Promotes Radial Glial Identity and Interacts with Notch1 Signaling in Telencephalic Progenitors , 2004, The Journal of Neuroscience.
[13] Guido Nikkhah,et al. NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts , 2009, Stem cells.
[14] Y. Jan,et al. Control of Daughter Cell Fates during Asymmetric Division: Interaction of Numb and Notch , 1996, Neuron.
[15] G. Hsu,et al. A Population-Based Cross-Over Randomized Controlled Trial of Breast Cancer Screening with Alternate Mammography and Ultrasound for Women Aged 40 to 49 Years in Taiwan. , 2009 .
[16] J. Minna,et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. , 2006, Cancer cell.
[17] T. Dang,et al. Notch3 Cooperates With the EGFR Pathway to Modulate Apoptosis Through The Induction Of Bim , 2009, Oncogene.
[18] S. Sisodia,et al. The Notch Ligands, Delta1 and Jagged2, Are Substrates for Presenilin-dependent “γ-Secretase” Cleavage* , 2003, The Journal of Biological Chemistry.
[19] S. Ogawa,et al. Dual antitumor mechanisms of Notch signaling inhibitor in a T‐cell acute lymphoblastic leukemia xenograft model , 2009, Cancer science.
[20] David J Anderson,et al. Transient Notch Activation Initiates an Irreversible Switch from Neurogenesis to Gliogenesis by Neural Crest Stem Cells , 2000, Cell.
[21] Yunqing Li,et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. , 2009, Cancer research.
[22] J. Aster,et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. , 2005, Blood.
[23] G. Serban,et al. A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions , 2002, The EMBO journal.
[24] J. Aster,et al. Modulation of Notch Signaling by Antibodies Specific for the Extracellular Negative Regulatory Region of NOTCH3* , 2008, Journal of Biological Chemistry.
[25] D. Stearns,et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. , 2006, Cancer research.
[26] G. Dontu,et al. Stem cells in normal breast development and breast cancer , 2003, Breast Cancer Research.
[27] F. Oswald,et al. NF-κB2 Is a Putative Target Gene of Activated Notch-1 via RBP-Jκ , 1998, Molecular and Cellular Biology.
[28] Yan Li,et al. Regulation of Notch1 and Dll4 by Vascular Endothelial Growth Factor in Arterial Endothelial Cells: Implications for Modulating Arteriogenesis and Angiogenesis , 2003, Molecular and Cellular Biology.
[29] Holger Gerhardt,et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis , 2007, Nature.
[30] Gavin Thurston,et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis , 2006, Nature.
[31] Arie Perry,et al. Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.
[32] Yunqing Li,et al. The Neuronal MicroRNA miR-326 Acts in a Feedback Loop with Notch and Has Therapeutic Potential against Brain Tumors , 2009, The Journal of Neuroscience.
[33] M. Bjørås,et al. Mitochondrial DNA Integrity Is Essential For Mitochondrial Maturation During Differentiation of Neural Stem Cells , 2010, Stem cells.
[34] D. Carvajal,et al. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. , 2009, Cancer research.
[35] Harald Steiner,et al. Presenilin-dependent Intramembrane Proteolysis of CD44 Leads to the Liberation of Its Intracellular Domain and the Secretion of an Aβ-like Peptide* , 2002, The Journal of Biological Chemistry.
[36] A. Gilmore,et al. Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. , 2009, Cancer research.
[37] T. Golde,et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor , 2008, Oncogene.
[38] L. R. Perumalsamy,et al. Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival , 2010, Proceedings of the National Academy of Sciences.
[39] Rong Wang,et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.
[40] T. Yeatman,et al. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. , 2010, Cancer research.
[41] L. Vassilev,et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.
[42] Tyra G. Wolfsberg,et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[43] U. Lendahl,et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.
[44] S. Lipkin,et al. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. , 2010, Cancer research.
[45] V. Orian-Rousseau. CD44, a therapeutic target for metastasising tumours. , 2010, European journal of cancer.
[46] C. Real,et al. Notch Pathway Modulation on Bone Marrow-Derived Vascular Precursor Cells Regulates Their Angiogenic and Wound Healing Potential , 2008, PloS one.
[47] Pritam Das,et al. NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo , 2003 .
[48] Doo Yeon Kim,et al. Nectin-1α, an Immunoglobulin-like Receptor Involved in the Formation of Synapses, Is a Substrate for Presenilin/γ-Secretase-like Cleavage* , 2002, The Journal of Biological Chemistry.
[49] Govind Bhagat,et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia , 2007, Nature Medicine.
[50] RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. , 2001, Development.
[51] J. Aster,et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. , 2006, Genes & development.
[52] E. Holland,et al. Notch signaling enhances nestin expression in gliomas. , 2006, Neoplasia.
[53] Iannis Aifantis,et al. γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia , 2009, Nature Medicine.
[54] Q. Su,et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. , 2005, Cancer research.
[55] G. Rebeck,et al. Regulation of ApoE receptor proteolysis by ligand binding. , 2005, Brain research. Molecular brain research.
[56] Q. Su,et al. Notch-1 regulates transcription of the epidermal growth factor receptor through p53. , 2008, Carcinogenesis.
[57] Jan Kitajewski,et al. Notch regulates the angiogenic response via induction of VEGFR-1 , 2010, Journal of angiogenesis research.
[58] T. Giordano,et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. , 2005, Cancer cell.
[59] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[60] A. Üren,et al. Small molecule selected to disrupt oncogenic protein EWS-FLI1 interaction with RNA Helicase A inhibits Ewing's Sarcoma , 2009, Nature Medicine.
[61] P. Delmas,et al. Osteoclast spreading kinetics are correlated with an oscillatory activation of a calcium-dependent potassium current , 2002, Journal of Cell Science.
[62] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[63] B. de Strooper,et al. Syndecan 3 Intramembrane Proteolysis Is Presenilin/γ-Secretase-dependent and Modulates Cytosolic Signaling* , 2003, Journal of Biological Chemistry.
[64] S. Ogawa,et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. , 2003, Immunity.
[65] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[66] G. Weinmaster,et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. , 1999, Human molecular genetics.
[67] P. Leder,et al. Ras pathway signals are required for notch-mediated oncogenesis , 2000, Oncogene.
[68] David Allman,et al. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. , 2004, Blood.
[69] Li Wang,et al. MicroRNA-206 Targets notch3, Activates Apoptosis, and Inhibits Tumor Cell Migration and Focus Formation* , 2009, The Journal of Biological Chemistry.
[70] L. Miele,et al. The Notch Ligand Jagged-1 Is Able to Induce Maturation of Monocyte-Derived Human Dendritic Cells1 , 2002, The Journal of Immunology.
[71] Keith L. Ligon,et al. Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies , 2007, Science.
[72] T. Suda,et al. Differentiation of arterial and venous endothelial cells and vascular morphogenesis. , 2006, Endothelium : journal of endothelial cell research.
[73] L. Miele,et al. Notch‐1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds , 1999, Journal of cellular biochemistry.
[74] Phil Jones,et al. Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells. , 2005, Genes & development.
[75] K. Garber. Notch emerges as new cancer drug target. , 2007, Journal of the National Cancer Institute.
[76] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[77] J-Z Qin,et al. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-κB and PPARγ , 2002, Cell Death and Differentiation.
[78] S. Baylin,et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. , 2001, Cancer research.
[79] P. S. Amieux,et al. Proteolytic Processing of the p75 Neurotrophin Receptor and Two Homologs Generates C-Terminal Fragments with Signaling Capability , 2003, The Journal of Neuroscience.
[80] B. Osborne,et al. Arbiter of differentiation and death: Notch signaling meets apoptosis , 1999, Journal of cellular physiology.
[81] K. Black,et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.
[82] L. Espinosa,et al. p65-NFkappaB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR. , 2002, Journal of cell science.
[83] Thijs J. Hagenbeek,et al. Therapeutic antibody targeting of individual Notch receptors , 2010, Nature.
[84] James M. Roberts,et al. Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1 , 2008, Science.
[85] D. Farber,et al. Transfer of MicroRNAs by Embryonic Stem Cell Microvesicles , 2009, PloS one.
[86] Wen Shi,et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. , 2007, Cancer research.
[87] G. Hannon,et al. miRNAs on the move: miRNA biogenesis and the RNAi machinery. , 2004, Current opinion in cell biology.
[88] A Cumano,et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. , 2000, Molecular cell.
[89] J. Campos-Ortega,et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. , 2001, Development.
[90] Y. Bessho,et al. Mouse Fbw7/Sel-10/Cdc4 Is Required for Notch Degradation during Vascular Development* , 2004, Journal of Biological Chemistry.
[91] Li-Xuan Qin,et al. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. , 2009, Cancer research.
[92] S. Korsmeyer,et al. Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.
[93] S. Weiss,et al. Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin Receptor , 2008, PLoS biology.
[94] L. Miele,et al. Human Notch-1 Inhibits NF-κB Activity in the Nucleus Through a Direct Interaction Involving a Novel Domain1 , 2001, The Journal of Immunology.
[95] J. Weissenbach,et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.
[96] W. Dalton,et al. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. , 2008, Blood.
[97] L. Parisiadou,et al. Presenilin 1 and Cadherins: Stabilization of Cell-Cell Adhesion and Proteolysis-Dependent Regulation of Transcription , 2004, Neurodegenerative Diseases.
[98] M. H. Angelis,et al. Maintenance of somite borders in mice requires the Delta homologue Dll1 , 1997, Nature.
[99] Yuri Kotliarov,et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.
[100] Olivier Pourquié,et al. Maintenance of neuroepithelial progenitor cells by Delta–Notch signalling in the embryonic chick retina , 1997, Current Biology.
[101] S. Artavanis-Tsakonas,et al. Notch signals control the fate of immature progenitor cells in the intestine , 2005, Nature.
[102] I. Onoyama,et al. Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7 , 2008, Oncogene.
[103] I. Stamenkovic,et al. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. , 2010, Cancer research.
[104] David Bilder,et al. Endosomal entry regulates Notch receptor activation in Drosophila melanogaster , 2008, The Journal of cell biology.
[105] D. Bartel,et al. MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.
[106] Richard A Flavell,et al. Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells , 2004, Cell.
[107] J. Best,et al. A novel series of potent γ-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core , 2005 .
[108] Tasuku Honjo,et al. Notch1 and Notch3 Instructively Restrict bFGF-Responsive Multipotent Neural Progenitor Cells to an Astroglial Fate , 2001, Neuron.
[109] B. Sullenger,et al. Notch Promotes Radioresistance of Glioma Stem Cells , 2009, Stem cells.
[110] B. de Strooper,et al. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. , 2002, Human molecular genetics.
[111] Hans Clevers,et al. Notch1 functions as a tumor suppressor in mouse skin , 2003, Nature Genetics.
[112] Minhong Yan,et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis , 2006, Nature.
[113] T. Ohtsuka,et al. The Notch-Hes pathway in mammalian neural development , 1999, Cell Research.
[114] Minhong Yan,et al. Chronic DLL4 blockade induces vascular neoplasms , 2010, Nature.
[115] Xu Ma,et al. Mouse microRNA-124 regulates the expression of Hes1 in P19 cells. , 2010, Frontiers in bioscience.